Soluble ENPP1 or ENPP3 Proteins and Uses Thereof
Summary
The European Patent Office published application EP4162036A1 for BioMarin Pharmaceutical Inc. and Yale University covering soluble ENPP1 or ENPP3 proteins and their uses. The patent application was published April 8, 2026 with A1 designation (first publication with European search report). The application designates all European contracting states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.
What changed
The European Patent Office published patent application EP4162036A1 filed by BioMarin Pharmaceutical Inc. and Yale University. The application covers soluble ENPP1 or ENPP3 proteins and their therapeutic uses, classified under IPC codes C12N 9/14, C12N 9/16, and A61K 38/46. The A1 publication indicates the European search report is included.\n\nThis publication establishes the patent's priority date and makes the technical disclosure publicly available. Competing pharmaceutical developers should review freedom-to-operate implications for any overlapping ENPP1/ENPP3 research programs. The patent designates all European contracting states, creating IP risk for those developing similar biopharmaceutical products in those jurisdictions.
Archived snapshot
Apr 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SOLUBLE ENPP1 OR ENPP3 PROTEINS AND USES THEREOF
Publication EP4162036A1 Kind: A1 Apr 08, 2026
Applicants
BioMarin Pharmaceutical Inc., Yale University
Inventors
CHENG, Zhiliang, BRADDOCK, Demetrios, STABACH, Paul, JUNGLES, Steven
IPC Classifications
C12N 9/14 20060101AFI20211217BHEP A61K 38/46 20060101ALI20211217BHEP C12N 9/16 20060101ALI20211217BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.